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dependent on the metabolic phenotype of
activated CD4+ T cells
Andrea Hegedus†, Maia Kavanagh Williamson† and Hendrik Huthoff*Abstract
Background: HIV-1, like all viruses, is entirely dependent on the host cell for providing the metabolic resources for
completion of the viral replication cycle and the production of virions. It is well established that HIV-1 replicates
efficiently in activated CD4+ T cells, whereas resting CD4+ T cells are refractory to infection with HIV-1. A hallmark of
T cell activation is the upregulation of glycolysis to meet the biosynthetic and bioenergetic needs of cell proliferation
and the execution of effector functions by the secretion of cytokines. To date, it has remained unknown if HIV-1 requires
the high glycolytic activity of activated T cells to support its replication.
Results: We report that in primary CD4+ T cells, the flux through the glycolytic pathway is increased upon infection with
HIV-1. This increase in glycolytic activity does not occur in T cell lines when infected with HIV-1. By providing cells with
galactose instead of glucose, the former being a poor substrate for glycolysis, we monitored the effect of preventing
glycolysis in CD4+ T cells on virus replication cycle and cell fate. We observed that HIV-1 infected primary CD4+ T
cells cultured in galactose have a survival advantage over those cultured in glucose and this coincides with reduced
caspase 3 activation and apoptosis in cultures with galactose. T cell lines do not recapitulate this difference in cell
death. Finally, we demonstrate that virion production is dependent on glycolysis as cultures containing galactose yield
reduced amounts of HIV-1 virions compared with cultures containing glucose.
Conclusions: The replication of HIV-1 in primary CD4+ T cells causes an increase in glycolytic flux of the cell. Glycolysis
is particularly required for virion production and additionally increases the sensitivity of the infected cell to virus-induced
cell death.
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As obligate intracellular parasites, viruses are dependent
on the host for provision of the biosynthetic and bio-
energetic resources required for the completion of the
viral life cycle. The study of viral exploitation and ma-
nipulation of cellular metabolism is an emerging field
that has yielded novel insights into viral replication strat-
egies and their therapeutic intervention in recent years
[1,2]. Numerous viruses have now been shown to cause
significant alterations in the metabolism of the host cell,
including hepatitis C, influenza, herpes simplex and hu-
man cytomegalovirus [3-7].* Correspondence: hendrik.huthoff@kcl.ac.uk
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unless otherwise stated.The best-studied case of changes to the cellular metab-
olism in response to viral infection is that of human
cytomegalovirus (HCMV). Cells that are infected with
HCMV show a greater uptake of glucose [8], elevated
glycolytic activity [4], efflux of citrate from the tricarb-
oxylic acid cycle (TCA cycle) [9], enhanced glutaminoly-
sis [10] and increased fatty acid and pyrimidine synthesis
[4,6,9]. Together, these studies have elucidated that the
production of the enveloped virus HCMV requires add-
itional fatty acid and nucleotide synthesis for the supply
of membrane and viral genomes to progeny virions, re-
spectively [2]. These biosynthetic processes are sup-
ported by the upregulation of glycolysis and the TCA
cycle. Importantly, the increased demand for fatty acid
synthesis in infected cells is met by cataplerosis of citrate
from the TCA cycle, which is replenished by anaplerosisal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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similar to the metabolic reprogramming observed upon
oncogenesis [2], suggesting that the biosynthetic needs of
virus replication are similar to those of proliferating cells.
The human immunodeficiency virus type 1 (HIV-1)
replicates most efficiently in activated CD4+ T cells and
it is the depletion of this compartment that heralds the
onset of AIDS. In contrast, quiescent or resting T cells
are refractory to infection by HIV-1 and this is in part
due to a block to reverse transcription as a result of the
low levels of nucleotides that are present in resting T cells
[11-13]. The activation of T cells upon antigen presenta-
tion is associated with a dramatic change in the metabolic
activity of the cell that is similar to oncogenic transform-
ation. T cell activation is initiated by a burst of increased
oxidative phosphorylation, which is followed by a substan-
tial upregulation of glycolysis as well as glutaminolysis
[14,15]. Because the upregulation of glycolysis exceeds
oxidative phosphorylation in activated T cells, secretion of
lactic acid is increased. The upregulation of glycolysis was
long thought to support the proliferation and execution of
effector functions of the activated T cells. However, recent
work by the Pearce group has shown that activation and
proliferation of T cells can be supported by oxidative
phosphorylation alone, but that the synthesis of cytokines
requires glycolytic metabolism [16].
There is mounting evidence that HIV-1 replication is
sensitive to, and modulates the activity of, host metabol-
ism. For instance, the recent discovery of the restriction
factor SAMHD1 has led to the insight that it hydrolyses
deoxynucleotide triphosphates (dNTPs) to levels that are
insufficient to support reverse transcription in mono-
cytes, macrophages, dendritic and quiescent CD4+ T cells
[17-21]. In addition, a recent metabolic profiling analysis
has revealed increased levels of glycolytic intermediates in
HIV-1 infected activated CD4+ T cells as well as an in-
crease in glucose uptake [22]. However, dependency of
HIV-1 replication on the metabolic activity of activated
CD4+ T cells has not previously been demonstrated. We
report here that infection with HIV-1 further increases the
glycolytic activity of activated primary CD4+ T cells and
that preventing glycolysis in infected cells is associated
with increased cell survival. Finally, we show that virion
production is dependent on the availability of glucose
to T cells.
Results
Infection with HIV-1 increases the rate of glycolysis of
primary CD4+ T cells but not T cell lines
We first sought to determine if the infection of CD4+ Tcells
with HIV-1 causes changes in flux through the glycolytic
pathway and the TCA cycle. We therefore monitored the
extracellular acidification rate (ECAR) as a measure for
glycolytic activity and the oxygen consumption rate (OCR)as a measure for oxidative phosphorylation in cultures con-
taining HIV-1 NL4.3 infected cells or cells treated with the
non-infectious Env-deleted virus, Δ Env (Figure 1 and
Additional file 1). In particular, baseline ECAR and
OCR were recorded in glucose-free DMEM with sub-
sequent sequential injections of glucose and the ATP
synthase inhibitor oligomycin. As expected, the addition
of glucose caused an increase in ECAR in all conditions
tested as it is metabolised through glycolysis to produce
lactic acid (Figure 1A). This coincides with a general drop
in OCR as the utilisation of glucose for ATP production
reduces the need for oxidative phosphorylation, known as
the Crabtree effect [23] (Figure 1B). The addition of oligo-
mycin causes a further increase in ECAR as upregulation
of glycolysis to its maximal capacity compensates for the
loss of mitochondrial ATP production, which is evidenced
by a drop in OCR to approximately 20% of the baseline.
We observed that the addition of glucose to primary
CD4+ T cells infected with HIV-1 NL4.3 consistently re-
sulted in a higher stimulation of ECAR over the baseline
than their uninfected counterparts (Figure 1A). While
uninfected cells showed an average fourfold induction of
the ECAR after addition of glucose, in HIV-1 NL4.3 in-
fected cells the ECAR always exceeded this with an aver-
age of a sixfold induction. Indeed, the ECAR of HIV-1
NL4.3 infected cells in the presence of glucose was
therefore of a similar magnitude as the maximal ECAR
of uninfected cells in the presence of oligomycin. HIV-1
infected primary CD4+ T cells showed little if any in-
crease of the ECAR after the addition of oligomycin
(Figure 1A), indicating that the infected cells are operat-
ing at or near their maximum glycolytic capacity. In
addition, the suppression of the OCR after addition of
glucose was more substantial in infected than in unin-
fected cells, with the OCR dropping to an average of
60% of the baseline instead of 80%, respectively (Figure 1B).
Similar results were obtained when cells were infected with
the HIV-1 isolate YU2 (Additional file 2). Together, these
results demonstrate that primary CD4+ T cells have an in-
creased rate of glycolysis upon infection with HIV-1. This
is consistent with a previous study that reported elevated
levels of glycolytic intermediates in the cytoplasm of HIV-1
infected cells as well as a moderate increase in glucose up-
take compared with uninfected cells [22]. In order to inves-
tigate if this may be related to changes in active glucose
transport, we assessed the levels of GLUT1 expression in
HIV-1 infected and uninfected cells by flow cytometry
(Additional file 3). GLUT1 is the main glucose transporter
in activated T cells; its expression on the cell surface is up-
regulated upon T cell activation [24-26] (Additional file
3D) and its silencing by RNAi inhibits HIV-1 replication
[27]. In these as well as subsequent experiments, we distin-
guished three populations of cells: uninfected cells that
received an inoculum of Δ Env virions or control
Figure 1 Monitoring glycolysis and oxidative phosphorylation in HIV-1 NL4.3 infected and uninfected CD4+ T cells upon provision of
glucose. A. The extracellular acidification rate (ECAR) and B. oxygen consumption rate (OCR) over time is given as a percentage of the baseline
recorded at 41 minutes in the absence of glucose for primary CD4+ T cells from three donors, CEM-ss and Jurkat cells. Vertical lines indicate the
injection of glucose and oligomycin, respectively. Data from primary CD4+ T cells represent single plates with 10 wells dedicated to each condition
and data for cell lines CEM-ss and Jurkat are the average of two plates. In all cases, infected cell populations were at least 70% positive for
HIV-1 p24Gag as determined by flow cytometry. Error bars represent the standard deviation and asterisks indicate p-values from an unpaired
t-test: *0.01 < p < 0.05, **0.005 < p < 0.01, ***p < 0.005, data points without an asterisk have non-significant differences.
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DSredX-negative population of cultures that received
wild type or reporter NL4.3 virus; and p24Gag/GFP/
DSredX-positive cells that are productively infectedwith HIV-1 NL4.3. We observed no difference in the intra-
cellular expression levels of GLUT1 in HIV-1 NL4.3 infected
and uninfected primary CD4+ T cells. When we assessed
the surface-expressed levels of GLUT1 in uninfected cells
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large difference between uninfected, bystander and infected
cells. However, a small shift in the median fluorescence in-
tensity of the GLUT1-positive cells in the NL4.3-DSredX in-
fected population compared with uninfected and bystander
cells was consistently observed. This suggests that there may
be a slight increase in the levels of surface-expressed
GLUT1 in HIV-1 infected cells (Additional file 3C).
We performed the same extracellular flux experiments
with Jurkat and CEM-ss cell lines (Figure 1A and B, and
Additional file 2). Unexpectedly, these experiments re-
vealed that neither cell lines are subject to an increased
glycolytic rate upon infection with HIV-1. In fact, Jurkat
cells infected with HIV-1 NL4.3 showed a lower ECAR
than their uninfected counterparts at all conditions
tested (Figure 1A). Both Jurkat and CEM-ss cell lines are
derived from leukemic T cells [28,29] and it has long
been appreciated that cancer causes considerable meta-
bolic changes to cells [30]. Evidently, this extends to the
metabolic response to the infection of these cells by
HIV-1.
Manipulating the metabolism of activated T cells by the
provision of glucose or galactose
Having established that primary CD4+ T cells increase
their glycolytic rate in response to infection with HIV-1,
we sought to manipulate the metabolism of the cell to
determine whether the glycolytic metabolism impacts on
the fate of the infected cell and the viral replication
cycle. This can be achieved by providing cells with the
alternative carbohydrate galactose instead of glucose.
Lymphocytes grown in galactose rely mostly on oxida-
tive metabolism [16]. Galactose is unable to enter the
glycolytic pathway directly but it can support cell prolif-
eration through entering the pentose phosphate pathway
[31]. Small amounts of galactose-derived carbon can
enter glycolysis via the Leloir pathway [32] but this
process is inefficient. We demonstrated this by monitor-
ing the ECAR and OCR of uninfected primary CD4+ T
cells upon the provision of either galactose or glucose,
with subsequent addition of oligomycin. Indeed, provision
of galactose failed to raise the ECAR to the extent that
glucose did (Figure 2A) in the absence or presence of oli-
gomycin. Furthermore, provision of galactose did not sup-
press the OCR (Figure 2B). When cells were provided
with galactose as well as glucose the results were identical
to those cultures treated with glucose only, demonstrating
that galactose does not interfere with the ability of cells to
metabolise available glucose. We performed the same ana-
lysis with Jurkat and CEM-ss cells (Figure 2A and B),
which demonstrated that the cell lines are likewise unable
to efficiently use galactose as a substrate for glycolysis.
Interestingly, the Crabtree effect is essentially absent from
CEM-ss cells. Infected primary CD4+ T cells, as well asJurkat and CEM-ss cells, showed no consistent differences
in ECAR and OCR upon provision of galactose compared
with uninfected cells (Additional file 4), suggesting that
oxidative metabolism of T cells is not grossly altered upon
infection with HIV-1.
In order to further characterise the impact of culturing
primary CD4+ T cells in galactose versus glucose, we
performed CFSE dilution experiments to monitor cell
proliferation. Primary CD4+ T cells are able to prolifer-
ate when provided with galactose as evidenced by gradual
dilution of the intracellular CFSE signal over a period of
four days (Figure 3A and Additional file 5). As was previ-
ously observed with murine CD4+ T cells [16], the human
primary CD4+ T cells showed a slight delay in prolifera-
tion rate when grown in media containing galactose
compared with glucose. This difference in proliferation
rate was not observed with CEM-ss cells (Figure 3A).
Throughout these experiments, cultures provided with
galactose as well as glucose behaved identically to those
provided with glucose only.
We also monitored the proliferation of HIV-1 NL4.3
infected cells and observed that proliferation of infected
primary CD4+ T cells cultured with glucose or galactose
was retarded compared with uninfected cells cultured
with glucose. The effect of culturing infected primary
CD4+ T cells in galactose on proliferation was variable,
with two donors presenting delayed proliferation com-
pared with infected cells provided with glucose whereas
the cells from donor 1 did not (Figure 3B and Additional
file 5). A difference in proliferation between infected
cells in media containing galactose or glucose was com-
pletely absent with CEM-ss cells (Figure 3B).
HIV-1 infected primary CD4+ T cells have a survival
advantage when cultured in galactose compared with
glucose
We next monitored the impact of providing cells with
galactose or glucose on the course of infection. Jurkat,
CEM-ss and primary CD4+ T cells were infected with
HIV-1 NL4.3 for 24 hours in standard RPMI media, after
which they were washed and split into cultures contain-
ing galactose, glucose or a mixture of both. This strategy
ensured that the cells experienced an identical level of
infection at the start of the experiment and that subse-
quent differences in the course of the infection would be
strictly due to the nature of the carbohydrate provided.
Samples were then taken each subsequent day for three
days and assessed for the proportion of HIV-1 infected
cells as determined by intracellular staining for the
viral p24Gag antigen. This revealed that the primary
CD4+ T cells from cultures provided with galactose
contained a higher proportion of HIV-1 NL4.3 infected
cells than cells from cultures containing glucose only
or a combination of glucose and galactose (Figure 4A
Figure 2 Galactose is an inefficient substrate for glycolysis in primary CD4+ T cells and T cell lines. A. The extracellular acidification rate
(ECAR) and B. oxygen consumption rate (OCR) over time is given as a percentage of the baseline recorded at 41 minutes in the absence of
carbohydrate substrate for primary CD4+ T cells from four donors, CEM-ss and Jurkat cells. Vertical lines indicate the injection of galactose, glucose
or a combination of the two and oligomycin, respectively. Data from primary CD4+ T cells represent the average from four plates with one donor
per plate. Data for CEM-ss and Jurkat cells are the average of three plates. Error bars represent the standard deviation and asterisks indicate p-values
from ANOVA with Tukey post-test relating to the differences between cultures containing galactose only and cultures containing glucose or glucose
and galactose: *0.01 < p < 0.05, **0.005 < p < 0.01, ***p < 0.005, data points without an asterisk have non-significant differences.
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tical significance on day four post infection (Figure 4C).
The cultures were also split into samples that addition-
ally received reverse transcriptase inhibitors (RTI) in
order to monitor differences occurring after one round
of infection only (Figure 4A and Additional file 6: +RTI).
In the presence of RTI a higher proportion of infected
cells in cultures containing galactose compared with glu-
cose was maintained. This implies that, as the initial level
of infection was identical, the difference in the amount of
cells that express viral p24Gag antigen is due to a difference
in the rate at which the infected cells succumb to cell
death in media containing galactose or glucose. Specif-
ically, HIV-1 infected primary CD4+ T cells grown in
cultures containing galactose appear to have a survival
advantage over infected cells grown in glucose. Strik-
ingly, no difference in the level of infection due to the
nature of the carbohydrate was observed with Jurkat
and CEM-ss cells, either in the presence or absence of
RTI (Figure 4B).As we had previously observed that the nature of the
carbohydrate does impact on the proliferation rate of
primary cells, we considered that the differential pro-
portion of HIV-1 infected cells could be affected by
outgrowth of uninfected cells. This could particularly
affect cultures containing glucose as this carbohydrate
supports faster proliferation. Thus, we sought to deter-
mine if the differences between cultures containing
galactose or glucose might be caused by an outgrowth
of uninfected cells in cultures containing glucose, thereby
reducing the relative proportion of infected cells. We
therefore determined the actual number of cells in
each sample using CountBright beads (Additional file 7).
When this adjustment was applied, counts of HIV-1
infected primary CD4+ T cells remained higher in cul-
tures containing galactose than in cultures containing
glucose.
We performed the same experiment with the YU2 iso-
late and again observed that cultures containing galact-
ose had a higher proportion of infected cells compared
Figure 3 Cell proliferation of HIV-1 infected and uninfected T cells in DMEM with galactose or glucose. A. Cell proliferation of T cells as
determined by CFSE dilution. Primary CD4+ T cells (donor 3) or T cells lines were stained with CFSE and cultured for 4 days in DMEM with 1 g/L
of either galactose, glucose or a combination of both. At day 1 and day 4 cells were harvested and analysed by flow cytometry. B. Proliferation of
primary CD4+ T cells, Jurkat and CEM-ss cells infected with HIV-1 NL4.3 (HIV-1) or non-infectious Env-deleted HIV-1 NL4.3 (Δ Env) in DMEM containing
1 g/L galactose or glucose. Data for HIV-1 infected cells represent the population of cells that were gated to contain p24Gag-expressing cells only.
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note that, compared with NL4.3, the magnitude of this
effect was lower in cells infected with YU2. The differ-
ence in the corrected amount of p24Gag positive cells in
cultures containing galactose or glucose was readilydiscernable in the presence of RTI for primary CD4+ T cells
infected with YU2. As with NL4.3, Jurkat and CEM-ss cells
infected with YU2 showed no difference in the amount
of p24Gag positive cells in response to the carbohydrate
provided.
Figure 4 Cells infected with HIV-1 NL4.3 have a survival advantage when cultured in media containing galactose compared with glucose.
A. Primary CD4+ T cells were infected with HIV-1 NL4.3 in RPMI with IL-2. After 24 hours cells were washed and seeded into DMEM containing
galactose, glucose or a combination of the two in the absence or presence of reverse transcriptase inhibitors (RTI). Cells were harvested at
24 hour intervals and analysed for intracellular HIV-1 p24Gag expression by flow cytometry. Data are shown as the percentage of p24Gag positive
cells. B. The percentage of p24Gag positive Jurkat and CEM-ss cells cultured in DMEM containing galactose, glucose or a combination of the two in the
absence or presence of reverse transcriptase inhibitors (RTI). C. Comparison of the percentage of p24Gag positive primary CD4+ T cells in cultures
containing galactose (gal) or glucose (glc) from five donors for each day in the time course experiment, with the associated p-values as calculated
with a paired t-test.
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cultured in glucose compared with galactose
To investigate the nature of the survival advantage that
HIV-1 infected cells experience in media containing gal-
actose, we measured the expression of several cellular
proteins that are known to impact on cell survival or
apoptosis. In particular, we assessed the intracellular ex-
pression of the pro-apoptotic activated caspase 3, the
regulator of cell survival pathways phosphorylated AKT1
(p-AKT1) and the anti-apoptotic Bcl2 by flow cytometry.
These cellular factors have all previously been implicated
in controlling cell death in HIV-1 infections [33-40].
We observed an increased proportion of cells express-
ing activated caspase 3 in infected primary CD4+ T cells
that were grown in glucose compared with infected cells
grown in galactose (Figure 5A and B). We note that a
slight enhancement of the number of cells expressing ac-
tivated caspase 3 was also apparent in uninfected and
bystander cells that were grown in glucose comparedwith galactose, suggesting that caspase 3 activation may
be more generally linked to glycolytic metabolism of the
cell. However, active caspase 3 in uninfected and by-
stander cells grown in glucose was markedly lower than
in infected cells, demonstrating that activation of cas-
pase 3 contributes to apoptotic cell death in HIV-1 in-
fected cells. The number of cells expressing activated
caspase 3 was also increased in primary CD4+ T cells
when infected with HIV-1 YU2 and cultured in the pres-
ence of glucose compared with galactose (Additional file 9).
Thus, we consistently observed that the number of cells ex-
pressing activated caspase 3 was low in cultures of primary
CD4+ T cells that contained galactose, which correlates with
their enhanced cell survival (Figure 4 and Additional files 6,
7 and 8). In contrast, activation of caspase 3 in infected
CEM-ss (Figure 5 and Additional file 9) and Jurkat (not
shown) cells was roughly an order of magnitude lower than
in the primary CD4+ T cells with either carbohydrate. Con-
sistent with a glycolysis-dependent mechanism of caspase 3
Figure 5 A greater proportion of cells infected with HIV-1 NL4.3 express activated caspase 3 when cultured in media containing glucose
compared with galactose. A. Scatter plots demonstrating the gating of p24Gag and activated caspase 3 positive populations of HIV-1 infected
primary CD4+ T cells and CEM-ss cells. The data shown correspond to day 2 post infection, which represents 1 day of culturing in media
containing 1 g/L galactose or glucose. B. The ratio of activated caspase 3 positive to negative cells after 24 hours of culturing in media containing
galactose or glucose for primary CD4+ T cells from 3 different donors and CEM-ss cells. C. The ratio of phosphorylated AKT1 (p-AKT1) positive to negative
cells after 24 hours of culturing in media containing galactose or glucose for primary CD4+ T cells from 3 different donors and CEM-ss cells. D. Percentage
of dead cells as determined by staining with propidium iodide of primary CD4+ T cells from three different donors and CEM-ss cells exposed to increasing
concentrations of PAPANONOate for 24 hours in media containing galactose or glucose. Experiments with primary cells were performed once for each
donor. Experiments with CEM-ss cells were performed in triplicate with the error bars indicating the standard deviation.
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with the reporter virus NL4.3-GFP contained greater popu-
lations of infected as well as uninfected cells that stained
positive with annexin V in cultures containing glucose com-
pared with galactose (Additional file 10). Again, this differ-
ence was not observed with CEM-ss cells.
The protein kinase AKT1 acts as a master regulator of
cell fate by controlling processes such as metabolism,
proliferation and apoptosis, and its kinase activity is ac-
tivated by phosphorylation [41,42]. We observed that
p-AKT1 is more abundant in HIV-1 infected CEM-ss
and primary CD4+ T cells, regardless of the carbohy-
drate provided in the cultures. A slight increase of p-AKT1
in NL4.3 infected cells cultured in galactose compared with
glucose was consistently observed in primary CD4+ T cells
but not in CEM-ss cells (Figure 5C). No differences in the
levels of p-AKT1 in response to the carbohydrate provided
was observed when primary CD4+ T cells were infected
with the HIV-1 YU2 isolate (Additional file 9). Thus, al-
though we cannot rule out that activation of AKT1 by
phosphorylation may contribute to the survival advantage
that HIV-1 infected primary CD4+ T cells experience in
cultures containing galactose, our current data do not sup-
port a major role for AKT1 in regulating cell survival in this
context. Likewise, investigation of the intracellular expres-
sion of Bcl2 by flow cytometry did not show a dependency
on the carbohydrate substrate (not shown). We did observe
that Bcl2 expression was increased in HIV-1 infected cells
as is consistent with a recent report [40].
It has recently been demonstrated that the translation
of the cytokines IL-2 and IFNγ is dependent on glyco-
lytic metabolism in murine CD4+ T cells [16]. IL-2 in
particular is known to affect T cell proliferation and its
translational regulation may therefore impact on the sur-
vival and expansion of the different cell populations in
our experiments. In addition, the provision of galactose
or glucose in the culture media may skew the proportion
of effector T cell subsets in our experiments through
glycolysis-driven control mechanisms. We therefore de-
termined the intracellular expression levels of IL-2, IL-4,
IFNγ and TNFα in the infected and uninfected CD4+ T
cell populations. These analyses indicated that there was
no effect of the choice of carbohydrate on the produc-
tion of these cytokines or the composition of Th1 and
Th2 compartments during the course of our experi-
ments (Additional file 11). It is important to note that in
our experiments primary CD4+ T cells were activated
and expanded in standard RPMI containing glucose for
up to five days prior to infection with HIV-1 and subse-
quent provision of either glucose or galactose. Therefore,
the initial burst of cytokine production after activation
would not have been subject to the effects mediated by
the provision of glucose or galactose in the culture
media [16]. We conclude therefore that, once activated,the differential survival of HIV-1 infected primary CD4+
T cells in cultures containing glucose or galactose is not
due to expression and autocrine action of IL-2, IL-4,
IFNγ or TNFα.
Because cells grown in galactose are mostly dependent
on oxidative phosphorylation for their metabolic needs,
we considered that this might impact on their sensitivity
to oxidative stress. The generation of reactive oxygen
species (ROS) in HIV-1 infected cells has been reported
to affect viral gene expression as well as HIV-induced
cell death [43-46]. In addition, it has been shown that
glucose protects epithelial cells and lymphocytes from oxi-
dative damage through the generation of ROS-scavenging
species such as lactate and pyruvate as well as by the
maintenance of reducing equivalents [47-49]. In order to
assess if oxidative damage may impact on the differential
survival of CD4+ T cells in media containing glucose or
galactose, we subjected the cells to oxidative damage by
the nitric oxide (NO) donor molecule PAPANONOate
and monitored cell death by staining with propidium
iodide (Figure 5D). Cells that were grown in glucose
consistently showed resistance to NO-induced cell death
compared with cells grown in galactose, and this was true
of primary CD4+ T cells, CEM-ss (Figure 5D) and Jurkat
cells (not shown). As glucose therefore confers resistance
to oxidative stress, we conclude that the increased survival
of HIV-1 infected cells grown in galactose is not attrib-
utable to mechanisms involving differences in oxida-
tive damage.
Glucose supports virion production during the HIV-1 life
cycle
We next set out to determine what stages of HIV-1 rep-
lication are affected by the nature of carbohydrate pro-
vided to target cells. To investigate the early stages of
HIV-1 replication, we seeded cells in media containing
either glucose or galactose and subsequently added equal
amounts of virus. After 24 hours, cells were harvested
and assessed for intracellular HIV-1 p24Gag levels. At
24 hours only a single round of HIV-1 infection would
have been completed and the amount of p24Gag expressed
in cells would therefore be the result of successful entry,
integration and viral gene-expression. We observed a
small but reproducible reduction of cells that stained
positive for p24Gag in cultures containing galactose
compared with glucose (Additional file 12). This indi-
cates that early steps of virus replication from entry to
gene-expression are moderately affected by the ability
of the target cell to perform glycolysis at the time of
infection.
To investigate effects of glycolysis on late stages of virus
replication, cells were infected in RPMI for 24 hours and
split into cultures containing galactose or glucose as be-
fore. Western blotting of the cell lysates revealed that
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was unaffected by culturing the cells in the presence of
glucose or galactose for a further 24 hours (Figure 6A and
B). Likewise, the intracellular level of HIV-1 Gag mRNA
was equivalent in media containing galactose or glucose
(Figure 6C). Interestingly, western blot analysis also revealed
that expression of glycolytic enzymes hexokinase 2 (HK2),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
pyruvate kinase M2 (PKM2) was unaffected by the identity
of the carbohydrate (Figure 6A). In addition, there was no
difference in the expression of these glycolytic enzymes in
uninfected and infected cells, as judged by western blotting
(Figure 6A). We also observed an increase in the levels
of activated caspase 3 in cultures containing glucose by
western blotting, with the highest proportion of cleaved
p19 to uncleaved p32 in HIV-1 NL4.3 infected cells
(Figure 6A and D).
Finally we assessed whether the carbohydrate metabol-
ism of HIV-1 infected cells affected the production of
viral particles. Cells were infected in RPMI and subse-
quently cultured in media containing galactose or glu-
cose for 24 hours. The supernatants of these culturesFigure 6 Expression of glycolytic enzymes and HIV-1 Gag in primary C
galactose or glucose. A. Western blot showing the expression of heat sho
dehydrogenase (GAPDH), pyruvate kinase M2 (PKM2), pro-caspase 3 (p32),
infected (NL4.3) and uninfected (Δ Env) primary CD4+ T cells for one repre
galactose are indicated with gal and lanes corresponding to cultures conta
and p55Gag HIV-1 in primary CD4+ T cells from cultures containing galactos
divided by the amount of HSP90 in each sample and normalised to the am
of a total of five western blots from independent infections of primary CD4
the standard deviation. C. The amount of HIV-1 unspliced mRNA relative to
Env as determined by qPCR. Data are normalised to the amount of HIV-1 G
independent infections of primary CD4+ T cells from three different don
caspase 3 p19 to pro-caspase 3 p32 in HIV-1 infected (NL4.3) and uninfected
glucose as quantified from western blots.were harvested and assessed for viral infectivity using
the indicator cell line TZM-bl and the presence of viral
p24Gag protein by western blotting (Figure 7A, B and C).
These analyses revealed that virion production in cul-
tures containing galactose was reduced to 20–60% of the
amount produced in cultures containing glucose. The
results from western blotting mirrored those obtained
from the infectivity assay with TZM-bl cells. We ob-
served the same reduction of virion production in cul-
tures containing galactose compared with glucose when
cell were infected with the HIV-1 YU2 isolate (not
shown). As the presence of intracellular Gag was un-
affected by culturing in galactose or glucose (Figure 6A),
these data indicate that there is a specific requirement
for glycolysis to support HIV-1 virion production. We
also performed experiments in which infected cells were
split into cultures containing only glucose or a mixture
of glucose and 2-deoxyglucose, which is a competitive
inhibitor of glycolysis (Additional file 13). The cultures
containing 2-deoxyglucose contained less virus in the
supernatant as assessed with the TZM-bl assay and west-
ern blotting, further supporting the notion that glycolysisD4+ T cells is not affected by culturing of cells in media containing
ck protein 90 (HSP90), hexokinase 2 (HK2), glyceraldehyde-3-phosphate
activated caspase 3 (p19) and HIV-1 Gag (p24Gag and p55Gag) in HIV-1
sentative donor (donor 2). Lanes corresponding to cultures containing
ining glucose are indicated with glc. B. The relative amount of p24Gag
e or glucose as quantified from western blots. p24Gag and p55Gag were
ount present in cultures containing glucose. The data are the average
+ T cells from three different donors with NL4.3. Errors bars represent
β-actin mRNA in primary CD4+ T cells infected with NL4.3 or NL4.3 Δ
ag mRNA in cultures containing glucose and are the average of five
ors. Error bars indicate the standard deviation. D. The ratio of activated
(Δ Env) primary CD4+ T cells from cultures containing galactose or
Figure 7 HIV-1 virion production is dependent on glycolysis. A. Infectivity of culture supernatants from HIV-1 NL4.3 infected primary CD4+ T cells,
Jurkat (Jur) and CEM-ss (CEM) cells that were cultured for 24 hours in media containing 1 g/L glucose or galactose, was determined by β-galactosidase
activity of the indicator cell line TZM-bl. B. Western blots showing the presence of p24Gag in the supernatant from cultures of HIV-1 NL4.3 infected
primary CD4+ T cells , Jurkat and CEM-ss in cultures containing 1 g/L galactose (gal) or glucose (glc). C. Quantified data from western blotting of
p24Gag shown in (B). All experiments were performed in triplicate and are shown as the average normalised to the infectivity of cultures containing
glucose. Error bars represent the standard deviation.
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noted that the number of live primary CD4+ Tcells in cul-
tures containing 2-deoxyglucose was reduced to approxi-
mately half that of the cultures containing glucose, whereas
Jurkat and CEM-ss cell viability was hardly affected by
2-deoxyglucose (not shown).
Discussion
We report an investigation into the dependency of HIV-1
infections on the highly glycolytic metabolism of its main
target cells, the activated CD4+ T cells. The elevated state
of glycolysis that persists in activated T cells is required to
support their effector functions, which place high bio-
synthetic demands on the cells to produce cytokines.
Although it was previously thought that the prolifera-
tion of activated T cells is driven mainly by glycolysis,
recent work has demonstrated that cell proliferation
can be fuelled by oxidative phosphorylation alone, whereas
cytokine production is inhibited in the absence of glucose
[16]. We therefore asked whether the anabolic metabolism
provided by activated T cells undergoing glycolysis might
be exploited by HIV-1 to support virus replication. Indeed,
we observed that both the fate of the HIV-1 infected cell
and HIV-1 virion production are dependent on glycolysis.
It had previously been demonstrated that HIV-1 in-
fected CD4+ T cells contain higher levels of glycolytic
intermediates [22]. However, increased levels of metabo-
lites may indicate either a higher rate of production or a
lower rate of depletion, and are therefore not indicative
of the activity of the pathway in question. Although
Hollenbaugh et al. demonstrated an increase in glucose
uptake in HIV-1 infected cells, intracellular levels of lactic
acid were similar to those of uninfected cells. In addition,
increased uptake of 2-deoxyglucose in HIV-1 infected H9
cells in culture has previously been reported [50]. Our
study complements those observations by demonstratingthat there is indeed increased flux through the glycolytic
pathway in primary CD4+ T cells upon infection with
HIV-1. Extracellular flux measurements in the presence of
oligomycin suggested that HIV-1 infected cells could be
operating at their maximal glycolytic capacity. We did
note a small shift in the median fluorescence intensity of
the surface-expressed glucose transporter GLUT1 on HIV-1
infected cells, which may suggest a small increase in the
abundance of the transporter in comparison with unin-
fected cells. However, this would only account for an
increase in glycolytic activity if glucose transport were
rate limiting to glycolysis in HIV-1 infected primary
CD4+ T cells. This remains to be established. In this
context, we note that increased expression of GLUT1
in CD4+ T cells from HIV-1 infected individuals has
recently been suggested as a marker of T cell activation
as well as being prognostic of disease progression [51].
Western blotting of several glycolytic enzymes suggested
that increased glycolytic flux proceeds without altering the
expression levels of these proteins in HIV-1 infected
primary CD4+ T cells. The HIV-1 mediated increase of
glycolysis may also be achieved by several possible
mechanisms including assembly of higher order com-
plexes, post-translational modification or allosteric regula-
tion of glycolytic enzymes. For example, it was recently
reported that the binding of the hepatitis C virus protein
NS5A increased the enzymatic activity of HK2, leading to
a general increase in glucose consumption and lactic acid
production [52]. On the other hand, infection of Vero cells
with mayaro virus was shown to increase the activity of
phosphofructokinase (PFK) [53]. Cells infected with her-
pes simplex virus were recently shown to have increased
glucose uptake and lactate efflux that correlated with
upregulation and phosphorylation of PFK [54]. In can-
cers, glycolytic flux is responsive to the assembly of
PKM2 into dimers or tetramers, which determines the
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or oxidative phosphorylation, respectively [55]. Exactly
how HIV-1 exerts control over glycolysis remains to be
determined.
We found no evidence to suggest that oxidative phos-
phorylation was affected in HIV-1 infected cells, which
is also in agreement with generally unaffected levels of
TCA cycle intermediates [22]. This suggests therefore
that HIV-1 replication has a specific requirement for re-
sources that derive from glycolysis. We only observed an
increase in glycolytic flux in primary CD4+ T cells after
infection with HIV-1 but not in the T cell lines Jurkat
and CEM-ss. Both these cell lines are derived from
leukemic patients and it is well established that a hall-
mark of transformed cells is the Warburg effect, which
is characterised by increased glycolytic activity despite
the presence of sufficient oxygen to support oxidative
phosphorylation [56]. Our results suggest that in these
cell lines glycolysis is de-regulated to the extent that
HIV-1 exerts no further control over the upregulation of
glycolysis.
By monitoring the number of cells that expressed
HIV-1 p24Gag in media containing galactose or glucose
we noted that a higher proportion of infected primary
CD4+ T cells was maintained in those cultures contain-
ing galactose. By the addition of reverse transcriptase inhib-
itors, we showed that this was independent of subsequent
rounds of infection and therefore suggested that galactose
provides infected cells with a survival advantage over
glucose. Indeed, a greater proportion of cells express-
ing activated caspase 3 was observed in the infected
primary CD4+ T cells cultured in glucose. We noted
that an increased proportion of cells expressing acti-
vated caspase 3 was not only observed in infected cells
but also in uninfected cells cultured in glucose, sug-
gesting a more general connection between glycolytic
metabolism and apoptotic cell death in activated CD4+
T cells. This was furthermore reflected in experiments
that revealed a greater proportion of infected as well as
uninfected cells that stained positive with annexin V in
cultures containing glucose compared with galactose.
Increased sensitivity of activated T cells to apoptosis
under conditions that favour glycolysis has been re-
ported [57] as well as the requirement for glycolytic
ATP production for apoptosis of Jurkat cells [58]. It
was recently reported that IL-2-dependent activation-
induced cell death of murine effector T cells is medi-
ated by activated caspase 3 and this was correlated with
increased glycolytic activity [59]. In addition, glycolysis-
dependent activation of caspase 3 was recently reported to
limit inflammatory cytokine production by a negative
feedback mechanism in macrophages after sustained acti-
vation [60]. In conjunction with our present work, these
studies point to a central role of caspase 3 in mediatingmetabolism-dependent contraction of immune responses
as well as pathogen-induced cell death. We emphasise that
we are not advocating a strict caspase 3-dependent mech-
anism of HIV-1 induced apoptotic cell death. Necrosis
[61] and necroptosis [62] have been observed in HIV-1
infected cells in addition to several possible modes of
apoptosis [33-36,39,61] and non-productively infected
cells were recently shown to die by caspase 1-mediated
pyroptosis [63].
In addition to an effect of cellular metabolism on HIV-1
induced cell death, we also observed that virus production
is more efficient in cells provided with glucose compared
with galactose. This is not unexpected, as glycolysis gener-
ates intermediates that support biosynthesis of amino
acids, lipids, nucleotides, glycolipids and glycoproteins. In
fact, it is likely that our experiments comparing cultures
containing galactose or glucose have underestimated the
dependency of HIV-1 virion production on glycolysis to
some extent. Galactose can be metabolised via the Leloir
pathway to produce UDP-galactose that can support nu-
cleotide sugar metabolism or be used to generate glucose-
1-phosphate that can enter glycolysis, albeit inefficiently.
Nevertheless, we observed that virus production in cul-
tures containing galactose was reduced to between 20%
and 60% of the amount produced in cultures containing
glucose. Likewise, the addition of 2-deoxyglucose to in-
fected cell cultures reduced the viral output severely,
but there is also some cellular toxicity associated with
2-deoxyglucose. To our knowledge, this is the first
time that a dependence of HIV-1 virion production on
glycolysis has been demonstrated.
There are several possibilities by which glucose would
be required for the synthesis of biomolecules that make
up the virion. For instance, there is evidence that lipid
metabolism is modulated in HIV-1 infected cells to sup-
port the formation of lipid microdomains that are the
preferred assembly sites for HIV-1 virions [64,65]. This
may pose an increased demand on the production of
precursor metabolites for lipid metabolism that are de-
rived from glycolysis, such as acetyl-CoA. In addition,
the gp120 subunit of the viral Env protein is one of the
most heavily glycosylated proteins found in nature and
its synthesis may well require an increase in sugar mole-
cules that are targeted into protein glycosylation path-
ways. Alternatively, there may be host factors that are
required for HIV-1 particle production whose expression
or activity depends on glycolytic metabolism. For ex-
ample, the translation of IFNγ and IL-2 mRNA is re-
pressed by the binding of GAPDH to the 3′ UTR when
it is not engaged in glycolytic catalysis [16]. It is conceiv-
able that other host protein that support HIV-1 replica-
tion may be subject to similar control mechanisms. Our
observation that HIV-1 Gag protein and its mRNA levels
are similar in cultures containing galactose or glucose
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not subject to translational control by GAPDH. Interest-
ingly, we observed that virus production was dependent
on the provision of glucose in cell lines as well as pri-
mary cells. Together, these results indicate that the
process of virion assembly has a metabolic requirement
that is conserved in primary CD4+ T cells and T cell
lines.Conclusions
We have demonstrated that the infection of primary
CD4+ T cells, but not T cell lines, with HIV-1 results in
an increased glycolytic flux. Furthermore, we have shown
that the engagement of glycolysis in infected primary CD4+
T cells makes them more susceptible to virus-mediated cell
death while at the same time supporting virion production.
Increased apoptosis and activation of caspase 3 was shown
to correlate with glycolytic activity of primary CD4+ Tcells,
both in the presence and absence of HIV-1.Methods
Extracellular flux measurements
Oxygen consumption and extracellular acidification rates,
OCR and ECAR respectively, were measured on an XF24
apparatus from Seahorse Biosciences. All extracellular flux
experiments were carried out in Dulbecco Modified Eagle
Medium (DMEM) reconstituted from powder formulation
(Sigma) supplemented with 10 mM pyruvate and 1 mM
glutamine but without sodium bicarbonate, phenol red or
serum. The DMEM was prepared on the day of the ex-
periment and adjusted to a pH between 7.2 and 7.4 at
37°C, and subsequently filter-sterilised. Cells were washed
once in DMEM and seeded at a density of 1.5 to 2.0 × 105
per well in XF24 culture plates that were coated with
Cell-Tak (BD biosciences) or poly-D-Lysine (Sigma)
and centrifuged for 5 minutes at 135 g at medium ac-
celeration. No differences in results were observed when
using Cell-Tak or poly-D-Lysine. After centrifugation, the
cell plate was directly loaded into the instrument. Glucose
and galactose were injected to a final concentration of 1 g/L
and oligomycin to a final concentration of 1 μM. HIV-1 and
uninfected cells were assayed 48 hours after infection, HIV-
1 infected cells stained at least 70% positive for viral p24Gag
antigen as determined by flow cytometry. In experiments
comparing addition of glucose, galactose and a combination
of the two, 7 wells were designated for each condition with
3 wells dedicated to background detection. In experiments
comparing the addition of glucose and galactose, 10 wells
were dedicated to each condition and 4 for background de-
tection. All results were normalised to the baseline OCR
and ECAR values recorded prior to the injection of sub-
strate. Data are represented as the average with error bars
indicating the standard deviation.Cell culture
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from whole blood by density centrifugation using
Lymphoprep (StemCell Technologies). CD4+ T cells were
isolated by magnetic activated cell sorting (MACS) by
negative selection (Miltenyi Biotec). The purity of the
isolated CD4+ T cell population was determined by
flow cytometry and was typically ≥95%. Cells were frozen
in 30% foetal bovine serum (FBS)/10% dimethyl-sulfoxide
(DMSO) until needed; upon which aliquots were thawed,
activated with CD3/CD28 T-cell activator Dynabeads
(12.5 μl per 106 cells) (Invitrogen) and cultured in RPMI-
1640 containing 10% FBS, 1% penicillin/streptomycin
(P/S) and 15 international units/ml (IU/ml) IL-2 for
4 days to expand (all Invitrogen). CD4+ T cells lines,
Jurkat and CEM-ss were maintained in RPMI-1640
containing 10% FBS and 1% P/S. Human Endothelial
Kidney 293 T (HEK 293 T) and TZM-bl cells [66,67]
were maintained in DMEM (Invitrogen) supplemented
with 10% FBS and 1% P/S. DMEM containing 1 g/L
galactose or glucose carbohydrate was made up using
the powder formulation of DMEM (Sigma) that lacks
glucose, pyruvate, sodium bicarbonate, glutamine and
phenol red: these components (Sigma) were added to
obtain the standard DMEM formulation. In addition,
10% dialysed FBS (Sigma), 1% P/S and 15 IU/ml IL-2
(both Invitrogen) were added and media passed through
0.2 μm filter to sterilise.
Virus production and infection
HIV-1 YU2 [68], NL4.3-nef-IRES-GFP (NL4.3-GFP) [69,70],
NLRX-IRES (NL4.3-DSredX) [71], NL4.3 [72] and negative
control Env-deleted virus (NL4.3 Δ Env [73,74]) virus were
produced by transfection of the molecular clones with PEI
(Polysciences) into HEK 293 T cells. YU2 viruses were pseu-
dotyped with the vesicular stomatitis virus glycoprotein
(VSV-G) by co-transfection of a VSV-G expression vector.
Supernatant from transfected cells was purified by filtering
through a 0.45 μm mixed cellulose membrane (Millipore)
and subsequent ultra-centrifugation over a 20% sucrose
cushion for 75 minutes at 28,000 rpm. Virus pellets were re-
suspended in glucose-free DMEM and virus infectivity was
then determined by titration on CEM-ss and Jurkat cells
with subsequent intracellular p24Gag staining and flow cy-
tometry analysis. The volume of viral stock needed to
achieve the desired percentage of infected cells was then cal-
culated for each experiment. For infection experiments, pri-
mary CD4+ T cells were re-activated with anti-CD3/CD28
beads and infected in RPMI + IL-2. Jurkat and CEM-ss cells
were infected in RPMI only. Following 24 hours incubation
at 37°C, cells were washed with PBS and seeded into
DMEM, containing IL-2 and 1 g/L galactose, glucose or a
combination of the two. Cells were infected and cultured in
the presence or absence of reverse transcriptase inhibitors
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through the NIH AIDS Reagent Program, Division of AIDS,
NIAID, NIH).
Flow cytometry
Infected cells were washed in PBS and treated with
TrypLE (Sigma) to remove membrane bound HIV-1, before
being permeabilised and fixed with Cytofix/Cytoperm
(BD Biosciences). Cells were then incubated with either
p24Gag antibody only or in combination with Bcl2 or cas-
pase 3 antibodies in Permwash (BD Biosciences). p-AKT1
was detected by washing cells in PBS, treating with TrypLE,
fixing in 4% paraformaldehyde and incubating with cold
Perm Buffer III (BD Biosciences) to capture the protein
in its phosphorylated form. Cells were incubated with
anti-p24Gag and p-AKT1 antibodies in FACS buffer
(PBS containing 2% FBS and 1% P/S). For detection of
intracellular cytokines (IL-2, IL-4, TNFα and IFNγ)
Brefeldin A (Biolegend) was added at 1:1000 to pri-
mary CD4+ T cells and incubated for 6 hours at 37°C.
Cells were then washed in PBS and incubated with
Live/Dead Fixable Dead Cell Stain Kit violet (Invitrogen)
for 30 minutes in the dark at room temperature (RT).
Next cells were washed, treated with TrypLE, fixed and
permeabilised with Cytofix/Cytoperm (BD Biosciences)
and stained with anti-p24Gag antibody plus either anti-
TNFα; IL-2 and IFNγ; or IL-4 and IFNγ. GLUT1 expres-
sion was detected in cells infected with NL4.3-GFP virus
after permeabilisation and fixing with Cytofix/Cytoperm
and incubated with mouse anti-human GLUT1 antibody
at RT for 30 minutes. After washing with FACS buffer
cells were incubated with anti-mouse-PE secondary anti-
body at RT for 30 minutes in the dark. Cells were washed
in FACS buffer 3 times then resuspended in FACS buffer
before being acquired on a FACSCantoII and analysed on
FlowJo software (Treestar). Where required, CountBright
Absolute Counting Beads (Invitrogen) were vortexed
for 30 seconds and 50 μl added to each sample prior
to acquisition. The following antibodies were used at
concentrations indicated in the manufactures’ instruc-
tions: anti-p24Gag-FITC and anti-p24Gag-RD1 KC57-
RD1 (Beckman Coulter), anti-Bcl2-PE-CF594 clone 100,
anti-activated caspase 3-FITC clone C92-605, anti-p-
AKT1-pacific blue clone M89-61, anti-TNFα-APC
clone 6401.1111, anti-IL-2-FITC clone 5344.11, anti-IL-4-
PE clone 3010.211, anti-IFNγ-APC clone 25723.11,
anti-CD4-PE RPA-T4 (all from BD Biosciences), anti-
GLUT-1 Ab40084 (Abcam), GLUT1-RBD-GFP (Metafora
Biosystems) and anti-mouse-PE secondary antibody
F0102B (R&D Systems).
Cell proliferation assay
Cells were washed twice in PBS (400 g/5mins) and re-
suspended in 1 μM CFSE for 10 minutes at RT in thedark (Invitrogen). The staining was quenched with sterile
FACS buffer for 2 minutes and then cells were washed in
fresh FACS buffer. Cells were seeded into media contain-
ing glucose, galactose or a combination of the two and left
to grow for the indicated times with subsequent analysis
by flow cytometry. For analysis of infected cells, staining
was performed in the same manner and cells were subse-
quently seeded into RPMI and given an inoculum of virus.
After 24 hours, the cells were washed and split into
DMEM containing glucose or galactose. At the indicated
time, cells were analysed by flow cytometry: cells were
gated for p24Gag expression to obtain the CFSE signal for
the HIV-1 infected population.
Cell death by oxidative damage
Uninfected cells were seeded in DMEM with galactose
or glucose and incubated for 24 hours at 37°C. PAPA-
NONOate (Cayman chemical) was added at the indi-
cated concentrations from a 30 mM stock solution in
DMSO and the cells were incubated at 37°C for a further
24 hours. Cells were then washed in PBS and stained
with propidium iodide (PI) as per the Vybrant Apoptosis
Assay Kit instructions (Invitrogen) and analysed by flow
cytometry.
Western blotting
Cell and supernatant samples were separated by SDS-
PAGE on an 11% SDS gel at 27 mA for 1 hour. Proteins
were then transferred onto nitrocellulose membranes at
16 V over night and blocked for 1 hour in 1% skimmed
milk in 0.1% Tween/PBS. Membranes were blotted with
primary antibodies for 1 hour at room temperature and
washed in 0.1% Tween/PBS. Subsequently, membranes
were blotted with secondary conjugated antibody for
1 hour at room temperature and washed again before
being visualised on a LI-COR Quantitative Imager. The
following antibodies were used according to the manu-
factures’ instructions: anti-HSP90 sc7947 (Santa Cruz),
anti-PKM2 ab38237 (Abcam), anti-HK2 ab104830 (Abcam),
anti-GAPDH ab8245 (Abcam), anti-caspase-3 9668S (Cell
Signaling), 800CW goat anti-rabbit 926–32211 (LI-COR)
and 680RD goat anti-mouse 926–68070 (LI-COR). HIV-1
Gag was detected with supernatant from the mouse
hybridoma 183-H12-5C, which was a kind gift from
Prof. M. Malim.
Infectivity assay
TZM-bl cells were plated at 1.5 × 105 per well in a 24-well
plate and incubated at 37°C O/N. The next day, 100 μl of
supernatant from infected cultures was added to each
well. After 24 hours incubation at 37°C, media was as-
pirated off and 100 μl of Galacto-Star Lysis solution
(Applied Biosciences) added to each well. Galacto-Star
Reporter Assay Kit for the detection of β-galactosidase
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the lysate according to the manufacturers’ instructions.
The value from negative control wells that received no
supernatant was subtracted from all experimental values to
account for any autoluminesence present in TZM-bl cells.
Quantitative real-time PCR
RNA was extracted using the Qiagen miRNeasy Mini kit ac-
cording to the manufacturer’s instructions. cDNA was syn-
thesised using High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) according to the manufac-
turer’s instructions. qPCR reactions were performed in
triplicate, using TaqMan Universal PCR master mix
(Applied Biosystems) with 900 nM of each primer and
250 nM probe. After 10 min at 95°C, reactions were
cycled through 15 sec at 95°C followed by 1 min at 60°C for
40 cycles. To detect HIV-1 genomic RNA the primers used
were GagupNL4.3 (AGGCTGTAGACAAATACTGGG)
and GagdownNL4.3 (TTTGATGCACACAATAGAG
GA) with the probe GagProbegRNA (FAM-CCCTTC
AGACAGGATCAGAAGAACTTAGATCA-TAM) (all from
Eurofins). As a cellular control β-actin mRNA was amplified
(Life technologies), which all data were normalised
against.
Statistics
Graphpad Prism software was used to perform paired t-test,
unpaired t-test and ANOVA with Tukey post-test to calcu-
late p-values as indicated.
Additional files
Additional file 1: Viral burden in infected primary CD4+ T cells and
cells lines that were subjected to extracellular acidification and
oxygen consumption experiments. Viral burden was assessed by
intracellular staining of viral p24Gag antigen of HIV-1 NL4.3 wt infected
cells compared with cells treated with NL4.3 Δ Env. A line on top of the
plots indicates the gating boundaries for p24Gag-positive cells and the
corresponding percentage of infected cells in the culture.
Additional file 2: Monitoring glycolysis and oxidative
phosphorylation in VSV-G-pseudotyped HIV-1 YU2 infected and
uninfected CD4+ T cells upon provision of glucose. A. The
extracellular acidification rate (ECAR) and B. oxygen consumption rate
(OCR) over time is given as a percentage of the baseline recorded at
41 minutes in the absence of glucose for primary CD4+ T cells from
three donors, CEM-ss and Jurkat cells. Vertical lines indicate the injection
of glucose and oligomycin, respectively. Data from primary CD4+ T cells
represent single plates with 10 wells dedicated to each condition and
data for cell lines CEM-ss and Jurkat are the average of three plates. In all
cases, infected cell populations were at least 70% positive for HIV-1
p24Gag as determined by flow cytometry. Error bars represent the
standard deviation and asterisks indicate p-values from an unpaired
t-test: *0.01 < p < 0.05, **0.005 < p < 0.01, ***p < 0.005, data points
without an asterisk have non-significant differences.
Additional file 3: Intracellular and surface GLUT1 expression in
infection of primary CD4+ T cells infected with HIV-1 NL4.3-GFP/DSredX.
Flow cytometry analysis of GLUT1 expression in primary CD4+ T cells from
three donors. Uninfected cells received control supernatant, infected cells
received an inoculum of GFP- or DSredX-expressing HIV-1 NL4.3 andbystander cells are the GFP/DSredX-negative population from the infected
cell samples. A. Intracellular staining for GLUT1 with antibody Ab40084
demonstrates that the level of GLUT1 expression within cells is not altered
upon infection with HIV-1 NL4.3-GFP. B. Staining of surface expressed GLUT1
with GLUT1-RBD-GFP of primary CD4+ T cells upon infection with
HIV-1 NL4.3-DSredX. C. Median fluorescence intensity of surface
expressed GLUT1 on HIV-1 NL4.3-DSredX infected and uninfected primary
CD4+ T cells. D. Upregulation of surface expressed GLUT1 upon activation
of primary CD4+ T cells.
Additional file 4: Monitoring glycolysis and oxidative
phosphorylation in HIV-1 NL4.3 infected and uninfected CD4+ T cells
upon provision of galactose. A. The extracellular acidification rate
(ECAR) and B. oxygen consumption rate (OCR) over time is given as a
percentage of the baseline recorded at 41 minutes in the absence of
glucose for primary CD4+ T cells from three donors, CEM-ss and Jurkat
cells. Vertical lines indicate the injection of galactose and oligomycin,
respectively. Data from primary CD4+ T cells represent single plates
with 10 wells dedicated to each condition and data for cell lines
CEM-ss and Jurkat are the average of two plates. Error bars represent
the standard deviation and asterisks indicate p-values from an unpaired
t-test: *0.01 < p < 0.05, **0.005 < p < 0.01, ***p < 0.005, data points
without an asterisk have non-significant differences.
Additional file 5: Cell proliferation of HIV-1 infected and uninfected
primary CD4+ T cells in DMEM with galactose or glucose. A. Cell
proliferation of T cells as determined by CFSE dilution. Primary CD4+ T
cells of donors 1 and 2 were stained with CFSE and cultured for 4 days in
DMEM with 1 g/L of either galactose, glucose or a combination of both.
At day 1 and day 4 cells were harvested and analysed by flow
cytometry. B. Proliferation of primary CD4+ T cells from donors 1 and
2 that were infected with HIV-1 NL4.3 (HIV-1) or non-infectious Env-deleted
HIV-1 NL4.3 (Δ Env) in DMEM containing 1 g/L galactose or glucose. Data for
HIV-1 infected cells represent the population of cells that were gated to
contain p24Gag-expressing cells only.
Additional file 6: Cells infected with HIV-1 NL4.3 have a survival
advantage when cultured in media containing galactose compared
with glucose. Primary CD4+ T cells from donors 4 and 5 were infected
with HIV-1 NL4.3 in RPMI with IL-2. After 24 hours cells were washed and
seeded into DMEM containing galactose, glucose or a combination of the
two in the absence or presence of reverse transcriptase inhibitors
(RTI). Cells were harvested at 24 hour intervals and analysed for intracellular
HIV-1 p24Gag expression by flow cytometry. Data are shown as the
percentage of p24Gag positive cells.
Additional file 7: The survival advantage of infected primary
CD4+ T cells cultured in media containing galactose compared
with glucose is not an artifact of outgrowth of uninfected cells
in cultures containing glucose. The data shown are derived from
those in Figure 4 and have been adjusted to represent actual cell
numbers after counting with CountBright beads according to the
manufacturer’s instructions.
Additional file 8: Cells infected with VSV-G-pseudotyped HIV-1 YU2
have a survival advantage when cultured in media containing galactose
compared with glucose. A. Primary CD4+ T cells were infected with
HIV-1 NL4.3 in RPMI with IL-2. After 24 hours cells were washed and
seeded into DMEM containing galactose, glucose or a combination of
the two in the absence or presence of reverse transcriptase inhibitors
(RTI). Cells were harvested at 24 hour intervals and analysed for intracellular
HIV-1 p24Gag expression by flow cytometry. Data are shown as the
percentage of p24Gag positive cells. B. Percentage of p24Gag positive
Jurkat and CEM-ss cells cultured in DMEM containing galactose, glucose or
a combination of the two in the absence or presence of reverse transcriptase
inhibitors (RTI). C. The data shown are derived from those in A and have been
adjusted to represent actual cell numbers after counting with CountBright
beads according to the manufacturer’s instructions.
Additional file 9: A greater proportion of cells infected with
VSV-G-pseudotyped HIV-1 YU2 express activated caspase 3
when cultured in media containing glucose compared with galactose.
A. The ratio of activated caspase 3 positive to negative cells after
24 hours of culturing in media containing galactose or glucose for
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http://www.retrovirology.com/content/11/1/98primary CD4+ T cells from 3 different donors and CEM-ss cells. B. The ratio
of phosphorylated AKT1 (p-AKT1) positive to negative cells after 24 hours
of culturing in media containing galactose or glucose for primary CD4+ T
cells from 3 different donors and CEM-ss cells. Uninfected cells received
an inoculum of control supernatant from cells that were transfected
with the VSV-G expression plasmid only.
Additional file 10: Primary CD4+ T cells cultured in glucose are
more susceptible to apoptosis compared with galactose. A. Scatter
plots demonstrating the gating of HIV-1 NL4.3-GFP and annexin V positive
populations of HIV-1 infected primary CD4+ T cells and CEM-ss cells. The
data shown correspond to day 2 post infection, which represents 1 day of
culturing in media containing 1 g/L galactose or glucose. B. The ratio of
annexin V positive to negative cells after 24 hours of culturing in media
containing galactose or glucose for primary CD4+ T cells from three
different donors and CEM-ss cells.
Additional file 11: Cytokine production in HIV-1 NL4.3 infected primary
cells is unaffected by culturing in galactose or glucose subsequent to
activation and infection. Analysis of intracellular cytokine expression of
HIV-1 infected cells after 24 hours of culturing in media containing galactose or
glucose for primary CD4+ T cells from three different donors. A. Analysis of the
intracellular expression of IL-2, IL-4 and IFNγ in HIV-1 NL4.3 infected cells that
were gated on the p24Gag positive population. The graphs indicate the
percentages of IL-2, IL-4 and IFNγ single positive as well as dual positive
populations as indicated on the right of the diagrams. B. The ratio of TNFα
positive to negative cells after 24 hours of culturing in media containing
galactose or glucose for primary CD4+ T cells from 3 different donors.
The HIV-1 NL4.3 culture was subdivided into bystander cells and HIV-1
infected cells by gating for p24Gag. Note that TNFα expression in cells
treated with HIV-1 NL4.3 Δ Env were not determined (ND) for donor 1.
Additional file 12: Early stages of HIV-1 replication are moderately
affected in cultures containing galactose compared with glucose.
Cells cultured in DMEM containing 1 g/L galactose, glucose or a
combination of the two were infected with HIV-1 NL4.3 and assessed for
intracellular p24Gag expression 24 hours later. The amount of p24Gag-positive
cells was normalised to the values obtained for cultures containing glucose.
Data represent eight independent infections with primary CD4+ T cells from
five donors. Error bars represent the standard deviation and asterisks
indicate p-values from ANOVA with Tukey post-test relating to the differences
between cultures containing galactose only and cultures containing glucose or
glucose and galactose: **0.005 < p< 0.01.
Additional file 13: HIV-1 virion production is dependent on glycolysis.
A. Infectivity of culture supernatants from HIV-1 NL4.3 infected primary
CD4+ T cells, Jurkat (Jur) and CEM-ss (CEM) cells cultured for 24 hours
in media containing 4.5 g/L glucose or 1 g/L glucose and 3.5 g/L
2-deoxyglucose was determined by β-galactosidase activity of the indicator
cell line TZM-bl. B. Western blots showing the presence of p24Gag in the
supernatant from cultures of HIV-1 NL4.3 infected primary CD4+ T cells, Jurkat
and CEM-ss in media containing glucose (glc) or glucose and 2-deoxyglucose
(2-DG). C. Quantified data from western blotting of p24Gag shown in (B).
All experiments were performed in triplicate and are shown as the
average, normalised to the infectivity of cultures containing glucose
and corrected for the number of live cells in the culture as determined
with CountBright beads. Error bars represent the standard deviation.
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